RxDoctor Payments Data

Kecia Christensen, APRN

Nurse Practitioner · Norfolk, NENPI 1326006008

Payments from drug & device makers

$1,206in general payments, 2019–2025

Across 72 payments — averaging $16.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$378
  • Grifols USA, LLC$96
  • GSK$94
  • Boehringer Ingelheim$71
  • Mylan Specialty L.p.$59
  • Amgen$51
  • plus $458 from 14 others

What the payments were for

  • Food & beverage$1,18898%
  • Education$182%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,206 in reported general payments places this provider in the 75th percentile of 924 nurse practitioner providers in Nebraska.

See all nurse practitioner providers in Nebraska

Medicare billing

Part B allowed, 2024
$6,658
Medicare patients
105
Services billed
152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter57$40,189
SymbicortBudesonide/Formoterol Fumarate22$7,647
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$4,790
Varenicline Tartrate20$4,655
Roflumilast14$696
Albuterol Sulfate HfaAlbuterol Sulfate12$469
Montelukast Sodium20$197
Gabapentin15$158
Oxycodone Hcl14$69

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta$94$44,98073 claims
AstraZenecaSymbicort$378$7,64722 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 924 nurse practitioner providers in Nebraska.

Other nurse practitioner in Norfolk

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →